Going concern
Filing comparison
OnKure Therapeutics, Inc. disclosed substantial doubt about its ability to continue as a going concern
Substantial doubt raised, alleviated by management's plans → Substantial doubt about ability to continue as a going concern
Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses and negative cash flows from operations that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Basis for Opinion These…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- substantial_doubt
- Current state label
- Substantial doubt about ability to continue as a going concern
- Direction
- escalated
- Located in
- going-concern note
- Prior filed
- 2025-03-10
- Prior form
- 10-K
- Prior state
- doubt_alleviated
- Prior state label
- Substantial doubt raised, alleviated by management's plans
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.